Creso Pharma Ltd

CPH Details

·        LOI signed with Cannapharm AG: Creso Pharma Ltd.’s (ASX: CPH) stock rose over 3.8% on June 01, 2017 after the company has signed a binding Letter of Intent (LOI) with Cannapharm AG. This is to provide patients in Asia Pacific and LATAM the access to top quality medicinal cannabis products from Switzerland, to address a variety of conditions as approved by prescribing physicians under relevant local legislations. CPH would capitalize on the first mover advantage to be exclusive distributor of highest quality Swiss-grade medicinal cannabis products into Asia Pacific and LATAM markets. The partnership would further enhance CPH’s market leadership position in the rapidly growing industry.

·         Recommendation: CPH stock fell over 15.05% (as of May 31, 2017) in the last three months owing to some volatility in the sector. We give a “Hold” recommendation at the current price of $ 0.41

Primary Health Care Ltd

 
PRY Details

·         Appointment of Acting Chief Executive Officer: Primary Health Care Ltd.’s (ASX: PRY) stock rose over 6.3% on June 01, 2017 leading to a total rally of over 15% in the last four weeks at the back of improving sentiments partly boosted by latest Federal Budget. Recently, PRY has announced that Mr Peter Gregg will step down as Managing Director and Chief Executive Officer; and Mr Malcolm Ashcroft, currently the Chief Financial Officer, has been appointed as Acting CEO, effective immediately.

·         Recommendation: PRY stock rose over 10.18% in the last three months (as of May 31, 2017) and is trading at slightly higher levels. We give an “Expensive” recommendation on the stock at the current price of $ 3.91

Northern Star Resources Ltd

NST Details

·         Mt Clement-Paulsens Gold/Silver Project: Northern Star Resources Ltd.’s (ASX: NST) stock rose over 4% on June 01, 2017 with gains in the sector and some improvement in market sentiments. The company owns 20% interests in Mt Clement-Paulsens Gold/Silver Project, and lately, Artemis Resources Limited has signed a binding joint development Memorandum of Understanding (MOU) with Blackrock Metals Pty Ltd, to immediately commence a full scoping study on Mt Clement-Paulsens gold and silver project in Western Australia. Moreover, Artemis and Blackrock would fund the costs of the study on a 50/50 basis with Blackrock managing the study process. On completion of the study, Artemis and Blackrock intend to proceed to a formal 50/50 joint venture to fund and develop Mt Clement-Paulsens.

·         Recommendation: NST stock rose over 37% in the last six months (as of May 31, 2017), and is trading at slightly high levels amidst the volatile gold price environment. We give an “Expensive” recommendation on the stock at the current price of $ 4.91

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.